Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-01-05 @ 5:49 PM
Study NCT ID:
NCT02256358
Status:
COMPLETED
Last Update Posted:
2014-10-20
First Post:
2014-10-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation
Sponsor:
Inje University
Organization:
Study Overview
Official Title:
Comparison of Effects of Intravenous Midazolam and Ketamine on Emergence Agitation : a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Compare the effects of intravenous midazolam and ketamine on emergence agitation after sevoflurane anesthesia
Detailed Description:
Emergence agitation is self-limiting aggressive behavior that develops in the early period of awakening from anesthesia. A high level of preoperative anxiety is a risk factor for emergence agitation using Aono's four-point scale. Midazolam and ketamine was administered to the patients to decrease of preoperative anxiety. We aimed to compare the emergence agitation between midazolam group and ketamine group.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: